SCLC Protocol

Header image  
The Knowledge for Health  
line decor
   HOME ::
line decor

SCLC Protocol

This protocol addresses the treatment aspects of treatment resistant Small Cell Lung Cancer, or SCLC.

SCLC is an agressive tumor category which frequently metastasizes widely. Cells from primary tumors in the are carried from the lungs in blood stream and often spread to peripheral organs, frequently the brain.

Conventional treatment of SCLC typically results in diminishing response to chemotherapy. In most cases, successive rounds increasing intensity of chemo therapy are required to suppress tumor progression.

Eventually tumor resilience surpasses patient therapeutic tolerance, and tumors overwhelms the patient. Therapeutic tolerance forces discontinuance of chemotherapy, and tumors progress unhindered either by patient autoimmunity or by therapeutic agents.

Adaptive resistance to conventional treatment is the primary basis for poor prognosis in SCLC cases.

There are several primary challenges with conventionally treated SCLC:

  • Persistence of highly resilient and adaptable tumor cells;
    • Vulnerable cells were eliminated by conventional therapy;
  • Collateral Damage from toxic therapy:
    • Autoimmune deficiency;
    • Progressive liver and digestive system dysfunction;
    • Systemic suppression of all adaptive cell lines
    • Resulting from Accumulated systemic toxicity
    • From both cancer toxins and and toxic therapy agents.
  • Initial vulnerability to cancer is unresolved
    • Toxicity
    • Immune Underperformance
    • Pathogenic involvement

Click here for a complete discussion of Malignancy Cofactors. This protocol is a an adapted version of the Malignancy Cofactors Protocol.

Immune Enhancement with Oxygen, nutrients and Heat

Manfred von Ardenne developed Oxygen Multistep Therapy. His tests showed an increase of 17% +-7% white blood cells within a very short time after the protocol. Similarly, hyperthermia is an accepted and proven therapy method in wide use for many years.

Here is the Oxygen Immune Enhancement Protocol page - strongly advised.


Cellular Detoxification

This detox protocol supports restoration of cellular functions inhibited by use of toxic therapeutic substances and energetics. Preferential use of cellular oxidative agents attached to glucose molecules installs plentiful toxins deeply into many if not most categories of cells which utilize glucose as an energy source.

This protocol segment utilizes a series of nutrients to mobilize and eliminate deeply embeded cellular toxins. The duration of this segment of the protocol is 8 weeks.

Lipoic Acid
600 mg
600 mg
  Cell Lipid Detoxification supporting cell membrane and working inside the blood/brain barrier.
Liposomal Myers Cocktail
Daily for first week.
Twice weekly thereafter.
Spectral detoxification & Methylation. Liposomal form preferred over IV.
Lipid Potassium

10 ml

First Week 10 ml


  Deliver potassium to potassium deplete cells resulting from long term membrane dysfunction.
Alkyglycerols 10 ml daily Metal Detoxificaiton for cellular lipid structures.
Urea Detox Reduce urea concentration and restore cellular Magnesium and Sulfur Reserves in support of normal metabolism.

Energetic Support

Energetic support is a key factor in limiting propogation of tumor cells:

  • Restoring Immunological Energetics enables immune cells to perform better;
  • Metabolic, particularly liver energetic support helps the liver eliminate accumulated agents and those released by breakdown;
  • Energetics to tissues adjacent to tumor cells helps these cells resist caustic chemical attack. This resistance helps to nutrients available for tumor cell propagation;
  • Energetics applied to tumor cells reduce the rate of propagation by increasing the transmembrane potential which when low, drives cellular reproduction;
  • In some cases pulsed fields have been documented to trigger apoptosis in tumor cells - this is not a consistent response, and depends on the method of application, the tumor cell line, and other other unknown variables;;
  • Enhances celluar absorption of therapeutic agents. PEMF at high levels triggers electroporation which causes cells to enter enhanced respiration for about 3 hours.
PEMF Exposure 15 minutes twice daily. Increase to 30 minutes according to tolerance. Expose tumor areas from 3 dimensions. Treat head, liver, spleen, kidney areas daily. Use for pain as needed. See list above
Exercise With Oxygen 5-30 minutes daily to tolerance. Optimizes plasma oxygen saturation to reduce tendency for pathological effects resulting from cellular hypoxia. Reduces oxygenic healing rate limits.
Hormetic ePad Bandage Wear continuously on surface as close as possible to any tumor. Suppress fungal and other pathogenic forms which contribute to malignancy.
Hormetic ePad

Place under sleep area

Provides systemic anti-inflammatory. Science Video Here.
Liposomal COQ10 2 teaspoons Provide metabolic energy cofactors to optmize cellular energy. Antioxidant.

Tumor Management Plan-A

These tumor management plans are organized by three criteria:

  • Degree and quality of supporting published and experience data;
  • Cost and convenience;

This is a tumor suppression protocol using complementary approach. It is a combination of protocols which are individually highly effective with most tumor lines.

This is an at-home protocol which uses supplements and strategies which are available in orally.

Protease and Lipase Enzymes 6 3 3 3 6 Increase level of circulating enzymes to aid in breakdown of wax coating which shields tumor cells from the immune system.
Beta Glucans 1/4 teaspoon at breakfast under tongue if tolerable.   Blocks glucose receptors in many tumor cell lines inhibiting absorption of preferred glucose nutrients.
Oral Sanguaranine Capsules


2 2 2   Antigenic compound which activates apoptosis, cell death in many tumor lines. Pubmed Results.
Selenium 245 2 Droppers at Breakfast   Initiate Cellular absorption of selenium and support liver detoxification.

Tumor Management Plan-B

These protocols utilize large quantities of substances which are limited to IV administration.

IV Vitamin C with oral lipoic acid 2-3x weekly Increasing from 50 grams to 100 or 150 depending on weight. Administer IV after PEMF to tumor area Exploits catalyase deficiency common to most tumor lines. Differential toxicity creates survival disadvantage to tumor cells. Riordan Patent
DMSO 2x weekly as prescribed. Includes glutathione and other push to support detoxification. Some individuals may tolerate oral DMSO, although IV administration is strongly preferred. Elevates oxygenic compounds, oxygen and sulfur, in tumor cells to stimulate oxidative failure due to catalayse deficiency.

Tumor Management Plan-C

These protocols utilizes adminstration of high amounts of selenium which selectively accumulate in tumor cells..

Selenated Eliostearic Acid 3-10 ml daily oral 70 of selenium accumulates in tumor cell cytoplasma triggering eventual apoptosis. Selenated Eliostearic Acid Patent
   Copyright 2005-2009, All Rights Reserved, Mark Squibb
Live Support